Approximately 159 Fewer Major Adverse Cardiovascular Events per 1000 Patients Studied
Data Show Relative Benefits of Vascepa Usage Grow Over Time
Amarin Schedules Webcast Discussion of Presented Data Today, March 18, 2019 at 4:00-5:00 pm CT
PR Newswire
BEDMINSTER, N.J. and DUBLIN, March 18, 2019